 |
1 Disease |  |
0 Trials |
|
0 Trials |  |
5 News |  |
- | INO-1800 / Inovio, INO-9112 / Inovio
Trial completion, Trial completion date, Trial primary completion date, Combination therapy: Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects (clinicaltrials.gov) - Jul 23, 2018
P1, N=90, Completed, Sponsor: Inovio Pharmaceuticals
Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> May 2018 | Trial primary completion date: Aug 2018 --> May 2018
- || INO-1800 / Inovio, INO-9112 / Inovio
Enrollment closed, P1 data, Combination therapy: Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects (clinicaltrials.gov) - Sep 11, 2017
P1, N=90, Active, not recruiting, Sponsor: Inovio Pharmaceuticals
Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> May 2018 | Trial primary completion date: Aug 2018 --> May 2018 Recruiting --> Active, not recruiting
- || INO-1800 / Inovio, INO-9112 / Inovio
P1 data, Enrollment change, Trial primary completion date, Combination therapy: Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects (clinicaltrials.gov) - Sep 9, 2016
P1, N=90, Recruiting, Sponsor: Inovio Pharmaceuticals
Recruiting --> Active, not recruiting N=126 --> 90 | Trial primary completion date: Dec 2018 --> Aug 2018
- || INO-1800 / Inovio, INO-9112 / Inovio
P1 data, Trial primary completion date, Combination therapy: Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects (clinicaltrials.gov) - Feb 24, 2016
P1, N=126, Recruiting, Sponsor: Inovio Pharmaceuticals
N=126 --> 90 | Trial primary completion date: Dec 2018 --> Aug 2018 Trial primary completion date: Nov 2017 --> Dec 2018
- ||| INO-1800 / Inovio, INO-9112 / Inovio
New P1 trial, P1 data, Combination therapy: Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects (clinicaltrials.gov) - May 1, 2015
P1, N=126, Recruiting, Sponsor: Inovio Pharmaceuticals